<< Revenir à la page d'accueil
13th november 2012
Maison de la Chimie, Paris
DEFINITIVE CANCER CURE THROUGH ONCOPROTEIN DEGRADATION
Hugues de THE
CNRS Inserm - Univeristé Paris Diderot - Hôpital Saint-Louis, Paris
⤢
DEFIVITIVE CANCER CURE THROUGH ONCOPROTEIN DEGRADATION
UNDERSTANDING THE MIRACLE OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) TO TRANSPOSE IT TO OTHER DISEASES
THE PML/RARA FUSION DRIVES ACUTE PROMYELOCYTIC LEUKEMIA
APL THERAPIES: RETINOIC ACID and ARSENIC
RA: TRANSCRIPTION THERAPY
RA & ARSENIC DEGRADE PML/RARA
SUN TZU: THE ART OF WAR (544-496 BC)
DISSECTING PML/RARA DEGRADATION PATHWAYS
THE RA/ARSENIC COMBINATION CURES APL IN ALL MICE and PATIENTS
LESSONS LEARNT FROM THE APL MODEL
TOWARDS OTHER DISEASES ?
INTERFERON and ARSENIC IN TAX-DRIVEN ADULT T CELL LEUKEMIA
Thanks
|«
«
▶||
»
»|
0:00:00